2-year safety and efficacy results for benralizumab

被引：4
|
作者：
Chung, Kian Fan [1 ,2 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Fac Med, London SW3 6LY, England
[2] Royal Brompton & Harefield NHS Fdn Trust, Resp Unit, London, England
来源：
LANCET RESPIRATORY MEDICINE | 2019年 / 7卷 / 01期
关键词：
SEVERE ASTHMA;
D O I：
10.1016/S2213-2600(18)30468-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：5 / 6
页数：3
相关论文
共 50 条
  • [31] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study
    Norito Katoh
    Yukihiro Ohya
    Hiroyuki Murota
    Masanori Ikeda
    Xiaofei Hu
    Kimitoshi Ikeda
    John Liu
    Takuya Sasaki
    Eliza M. Raymundo
    Henrique D. Teixeira
    Hidehisa Saeki
    Dermatology and Therapy, 2023, 13 : 221 - 234
  • [32] Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study
    Ogata, Atsushi
    Amano, Koichi
    Dobashi, Hiroaki
    Inoo, Masayuki
    Ishii, Tomonori
    Kasama, Tsuyoshi
    Kawai, Shinichi
    Kawakami, Atsushi
    Koike, Tatsuya
    Miyahara, Hisaaki
    Miyamoto, Toshiaki
    Munakata, Yasuhiko
    Murasawa, Akira
    Nishimoto, Norihiro
    Ogawa, Noriyoshi
    Ojima, Tomohiro
    Sano, Hajime
    Shi, Kenrin
    Shono, Eisuke
    Suematsu, Eiichi
    Takahashi, Hiroki
    Tanaka, Yoshiya
    Tsukamoto, Hiroshi
    Nomura, Akira
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (05) : 799 - 809
  • [33] Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry
    Burke, Martin C.
    Gold, Michael R.
    Knight, Bradley P.
    Barr, Craig S.
    Theuns, Dominic A. M. J.
    Boersma, Lucas V. A.
    Knops, Reinoud E.
    Weiss, Raul
    Leon, Angel R.
    Herre, John M.
    Husby, Michael
    Stein, Kenneth M.
    Lambiase, Pier D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (16) : 1605 - 1615
  • [34] Efficacy and safety of lurasidone in children and adolescents with bipolar depression: Results from a 2-year open-label extension study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S236 - S236
  • [35] Efficacy and safety of levetiracetam in pediatric patients with epilepsy: a 2-year follow up.
    Hovinga, CA
    PHARMACOTHERAPY, 2003, 23 (10): : 1350 - 1351
  • [36] The efficacy and safety of rifaximin-a: a 2-year observational study of overt hepatic encephalopathy
    Oey, Rosalie
    Buck, Lennart E. M.
    Erler, Nicole
    Van Buuren, Henk
    De Man, Robert
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E668 - E668
  • [37] Safety and efficacy of Coronary Sinus Reducer implantation at 2-year follow-up
    Ponticelli, Francesco
    Tzanis, Giorgos
    Gallone, Guglielmo
    Baldetti, Luca
    Mangieri, Antonio
    Colombo, Antonio
    Giannini, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 292 : 87 - 90
  • [38] Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Dubanchet, A.
    HAEMOPHILIA, 2012, 18 : 23 - 24
  • [39] Efficacy, durability, and safety of faricimab in diabetic macular edema: 2-year results from the phase 3 YOSEMITE and RHINE trials
    Lim, Jennifer I.
    Wells, John A.
    Eichenbaum, David Aaron
    Danzig, Carl J.
    Asik, Kemal
    Haskova, Zdenka
    Mohan, Shaun
    Silverman, David
    Tang, Yannan
    Lin, Hugh
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [40] BIMEKIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Thaci, Diamant
    Gottlieb, Alice B.
    Asahina, Akihiko
    Lebwohl, Mark
    McInnes, Iain B.
    Warren, Richard
    Boehncke, Wolf-Henning
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Merola, Joseph F.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
12345